EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype
Nenhuma Miniatura disponível
Data
2013-10-01
Autores
de Carvalho, Samara Camaçari
Apolinário, Leticia Montanholi
Matheus, Selma Maria Michelin
Santo Neto, Humberto
Marques, Maria Julia
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
In dystrophic mdx mice and in Duchenne muscular dystrophy, inflammation contributes to myonecrosis. Previously, we demonstrated that eicosapentaenoic acid (EPA) decreased inflammation and necrosis in dystrophic muscle. In the present study, we examined the effects of EPA and the corticoid deflazacort (DFZ) as modulators of M1 (iNOS-expressing cells) and M2 (CD206-expressing cells) macrophages. Mdx mice (14 days old) received EPA or DFZ for 16 days. The diaphragm, biceps brachii and quadriceps muscles were studied. Immunofluorescence, immunoblotting and ELISA assays showed that EPA increased interleucin-10, reduced interferon-γ and was more effective than DFZ in promoting a shift from M1 to M2. © 2013 Elsevier B.V. All rights reserved.
Descrição
Palavras-chave
Deflazacort, Dystrophy, EPA, Inflammation, M1 macrophages, M2 macrophages
Como citar
Journal of Neuroimmunology.